CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lorincz, 2014, Cancer diagnostic classifiers based on quantitative DNA methylation, Expert Rev Mol Diagn, 14, 293, 10.1586/14737159.2014.897610
Kanwal, 2010, Epigenetics and cancer, J Appl Physiol (1985), 109, 598, 10.1152/japplphysiol.00066.2010
Spitzwieser, 2015, Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer, Breast Cancer Res, 17, 125, 10.1186/s13058-015-0637-5
van Roy, 2008, The cell-cell adhesion molecule E-cadherin, Cell Mol Life Sci, 65, 3756, 10.1007/s00018-008-8281-1
Drees, 2005, Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly, Cell, 123, 903, 10.1016/j.cell.2005.09.021
Yamada, 2005, Deconstructing the cadherin-catenin-actin complex, Cell, 123, 889, 10.1016/j.cell.2005.09.020
Andrews, 2012, The role and function of cadherins in the mammary gland, Breast Cancer Res, 14, 203, 10.1186/bcr3065
De Leeuw, 1997, Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ, J Pathol, 183, 404, 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9
Berx, 1996, E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain, Oncogene, 13, 1919
Derksen, 2006, Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis, Cancer Cell, 10, 437, 10.1016/j.ccr.2006.09.013
Acs, 2001, Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications, Am J Clin Pathol, 115, 85, 10.1309/FDHX-L92R-BATQ-2GE0
Benton, 2009, Laminin-1 induces E-cadherin expression in 3-dimensional cultured breast cancer cells by inhibiting DNA methyltransferase 1 and reversing promoter methylation status, FASEB J, 23, 3884, 10.1096/fj.08-128702
Cheng, 2001, Mechanisms of inactivation of E-cadherin in breast carcinoma: Modification of the two-hit hypothesis of tumor suppressor gene, Oncogene, 20, 3814, 10.1038/sj.onc.1204505
Edge, 2010, The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM, Ann Surg Oncol, 17, 1471, 10.1245/s10434-010-0985-4
Elston, 1991, Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up, Histopathology, 41, 154
Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262
Herman, 1996, Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands, Proc Natl Acad Sci USA, 93, 9821, 10.1073/pnas.93.18.9821
Bertolo, 2008, Differences and molecular immunohistochemical parameters in the subtypes of infiltrating ductal breast cancer, Am J Clin Pathol, 130, 414, 10.1309/J3QV9763DYPV338D
Sebova, 2011, RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer, Cancer Biomark, 10, 13, 10.3233/CBM-2012-0230
Caldeira, 2006, CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer, BMC Cancer, 6, 48, 10.1186/1471-2407-6-48
Shinozaki, 2005, Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis, Clin Cancer Res, 11, 2156, 10.1158/1078-0432.CCR-04-1810
Tao, 2011, Promoter methylation of E-cadherin, p16 and RAR-β (2) genes in breast tumors and dietary intake of nutrients important in one-carbon metabolism, Nutr Cancer, 63, 1143, 10.1080/01635581.2011.605982
Nass, 2000, Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer, Cancer Res, 60, 4346
Parrella, 2004, Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors, Clin Cancer Res, 10, 5349, 10.1158/1078-0432.CCR-04-0555
Horne, 2014, Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression, Breast Cancer Res Treat, 143, 181, 10.1007/s10549-013-2771-z
Berx, 2009, Involvement of members of the cadherin superfamily in cancer, Cold Spring Harb Perspect Biol, 1, a003129, 10.1101/cshperspect.a003129
Tryndyak, 2010, E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells, Int J Cancer, 126, 2575, 10.1002/ijc.24972
Berletch, 2007, A method to study the expression of DNA methyltransferases in aging systems in vitro, Methods Mol Biol, 371, 81, 10.1007/978-1-59745-361-5_7
Plass, 2002, DNA methylation, imprinting and cancer, Eur J Hum Genet, 10, 6, 10.1038/sj.ejhg.5200768
Denis, 2011, Regulation of mammalian DNA methyltransferases: A route to new mechanisms, EMBO Rep, 12, 647, 10.1038/embor.2011.110
Cavusoglu, 2010, Promoter methylation and expression changes of CDH1 and P16 genes in invasive breast cancer and adjacent normal breast tissue, Neoplasma, 57, 465, 10.4149/neo_2010_05_465
Holm, 2010, Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns, Breast Cancer Res, 12, R36, 10.1186/bcr2590
Pathiraja, 2010, Epigenetic regulation in estrogen receptor positive breast cancer-role in treatment response, J Mammary Gland Biol Neoplasia, 15, 35, 10.1007/s10911-010-9166-0
Kominsky, 2004, Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain and lung, Clin Cancer Res, 10, 3104, 10.1158/1078-0432.CCR-03-0118
Lombaerts, 2006, E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial -to- mesenchymal transition in breast cancer cell lines, Br J Cancer, 94, 661, 10.1038/sj.bjc.6602996
van Horssen, 2012, E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells, Breast Cancer Res Treat, 136, 365, 10.1007/s10549-012-2261-8
Chao, 2010, Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition, Mol Cancer, 9, 179, 10.1186/1476-4598-9-179
Droufakou, 2001, Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast, Int J Cancer, 92, 404, 10.1002/ijc.1208